Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) GROUP BASED ON MEDICARE | Back to Top |
| DRG Code | DRG Description | Category | Sub Category | DRG Group | Surgical Category | Case Mix Level | Total National Projected Hospitalizations - Annualized | Total Medicare Hospitalizations - Jan 2017 to Dec 2017 | Total Medicare Hospitalizations - Jan 2013 to Dec 2017 | Total Medicare Hospitalizations After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 809 | MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | Non Surgical | 61.78 | NA | 15,133 | 83,718 | 80,784 | ||||||||||||
| 808 | MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | Non Surgical | 29.57 | NA | 7,875 | 40,065 | 35,361 | ||||||||||||
| 810 | MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | Non Surgical | 8.65 | NA | 2,118 | 11,721 | 11,216 |
DEMOGRAPHIC DETAILS OF DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Race | Total Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|
| White | 70,796 | 84.56 |
| Black | 7,190 | 8.59 |
| Hispanic | 1,640 | 1.96 |
| Age Group ( Years ) | Total Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|
| 65 to 69 | 20,655 | 24.67 |
| 70 to 74 | 18,595 | 22.21 |
| 75 to 79 | 14,812 | 17.69 |
TOP ICD DIAGNOSIS CODES FOR DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| ICD Code | ICD Description | Total ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| 78061 | Fever presenting with conditions classified elsewhere | 24,089 | 28.77 |
| 4019 | Unspecified essential hypertension | 22,468 | 26.84 |
| 28800 | Neutropenia, unspecified | 21,210 | 25.34 |
TOP ICD PROCEDURE CODES FOR DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| ICD Code | ICD Description | Total Procedure ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| 9904 | Transfusion Of Packed Cells | 23,507 | 28.08 |
| 30233N1 | Transfusion of Nonautologous Red Blood Cells into Peripheral Vein, Percutaneous Approach | 10,742 | 12.83 |
| 9905 | Transfusion Of Platelets | 8,717 | 10.41 |
TOP HOSPITALS ASSOCIATED WITH DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Hospital Name | Address | City | State | Zip Code | Total Hospital & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 1275 YORK AVE | New York | NY | 10065 | 649 | 0.78 |
| University of Texas MD Anderson Cancer Center | 1515 HOLCOMBE BLVD | Houston | TX | 77030 | 482 | 0.58 |
| The Johns Hopkins Hospital | 600 N WOLFE ST | Baltimore | MD | 21287 | 342 | 0.41 |
TOP ATTENDING PHYSICIAN ASSOCIATED WITH DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. SHALINI MULAPARTHI | 1730 LAKELAND HILLS BLVD | LAKELAND | FL | 33805 | 51 | 0.06 |
| DR. SATINDERJIT S OBEROI | 902 N RIVERSIDE RD | SAINT JOSEPH | MO | 64507 | 45 | 0.05 |
| DR. HELEN H. CHUNG | 1275 YORK AVE | NEW YORK | NY | 10065 | 44 | 0.05 |
DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) SUMMARY TABLE | Back to Top |
| Category | Sub Category | DRG Group | ICD Codes | ICD Description | National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - All) Jan 2013 to Dec 2017 | National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Yes) Jan 2013 to Dec 2017 | National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Not Y) Jan 2013 to Dec 2017 | Total Discharges After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | 78061 | Fever presenting with conditions classified elsewhere | NA | 24,089 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | 4019 | Unspecified essential hypertension | NA | 22,468 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | 28800 | Neutropenia, unspecified | NA | 21,210 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | R5081 | Fever presenting with conditions classified elsewhere | 29,818 | 17,088 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | I10 | Essential (primary) hypertension | 16,672 | 16,207 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | 2724 | Other and unspecified hyperlipidemia | NA | 14,797 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | 28419 | Other pancytopenia | NA | 14,669 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | T451X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter | 20,582 | 13,565 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | 28411 | Antineoplastic chemotherapy induced pancytopenia | NA | 13,515 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | V1582 | Personal history of tobacco use | NA | 11,968 |